nodes	percent_of_prediction	percent_of_DWPC	metapath
Cabazitaxel—Disease progression—Carmustine—malignant glioma	0.02	0.0612	CcSEcCtD
Cabazitaxel—TUBA4A—pineal body—malignant glioma	0.0186	0.0815	CbGeAlD
Cabazitaxel—Cerebral haemorrhage—Carmustine—malignant glioma	0.0079	0.0241	CcSEcCtD
Cabazitaxel—Cerebral haemorrhage—Temozolomide—malignant glioma	0.00764	0.0233	CcSEcCtD
Cabazitaxel—Docetaxel—BCL2—malignant glioma	0.00764	0.377	CrCbGaD
Cabazitaxel—Paclitaxel—BCL2—malignant glioma	0.00764	0.377	CrCbGaD
Cabazitaxel—Febrile neutropenia—Carmustine—malignant glioma	0.00727	0.0222	CcSEcCtD
Cabazitaxel—Transaminases increased—Carmustine—malignant glioma	0.00719	0.022	CcSEcCtD
Cabazitaxel—Haemorrhoids—Temozolomide—malignant glioma	0.00719	0.022	CcSEcCtD
Cabazitaxel—Febrile neutropenia—Temozolomide—malignant glioma	0.00703	0.0215	CcSEcCtD
Cabazitaxel—Deep vein thrombosis—Temozolomide—malignant glioma	0.00695	0.0212	CcSEcCtD
Cabazitaxel—TUBA4A—brainstem—malignant glioma	0.00581	0.0254	CbGeAlD
Cabazitaxel—TUBB8—central nervous system—malignant glioma	0.00566	0.0247	CbGeAlD
Cabazitaxel—Herpes zoster—Temozolomide—malignant glioma	0.00562	0.0172	CcSEcCtD
Cabazitaxel—TUBA4A—retina—malignant glioma	0.0056	0.0245	CbGeAlD
Cabazitaxel—TUBA4A—telencephalon—malignant glioma	0.00516	0.0225	CbGeAlD
Cabazitaxel—TUBB4A—embryo—malignant glioma	0.00508	0.0222	CbGeAlD
Cabazitaxel—Docetaxel—EGFR—malignant glioma	0.005	0.246	CrCbGaD
Cabazitaxel—TUBB4A—brainstem—malignant glioma	0.00466	0.0204	CbGeAlD
Cabazitaxel—TUBB4A—retina—malignant glioma	0.00449	0.0196	CbGeAlD
Cabazitaxel—TUBB8—brain—malignant glioma	0.00449	0.0196	CbGeAlD
Cabazitaxel—TUBB2B—retina—malignant glioma	0.00434	0.019	CbGeAlD
Cabazitaxel—Urinary incontinence—Carmustine—malignant glioma	0.00423	0.0129	CcSEcCtD
Cabazitaxel—Candida infection—Carmustine—malignant glioma	0.00418	0.0128	CcSEcCtD
Cabazitaxel—TUBB4A—telencephalon—malignant glioma	0.00413	0.0181	CbGeAlD
Cabazitaxel—Urinary incontinence—Temozolomide—malignant glioma	0.00408	0.0125	CcSEcCtD
Cabazitaxel—TUBA4A—medulla oblongata—malignant glioma	0.00405	0.0177	CbGeAlD
Cabazitaxel—Candida infection—Temozolomide—malignant glioma	0.00404	0.0123	CcSEcCtD
Cabazitaxel—TUBB2B—telencephalon—malignant glioma	0.00399	0.0175	CbGeAlD
Cabazitaxel—TUBB4B—embryo—malignant glioma	0.00396	0.0173	CbGeAlD
Cabazitaxel—TUBB3—central nervous system—malignant glioma	0.00386	0.0169	CbGeAlD
Cabazitaxel—Sepsis—Carmustine—malignant glioma	0.0038	0.0116	CcSEcCtD
Cabazitaxel—TUBB—telencephalon—malignant glioma	0.00378	0.0165	CbGeAlD
Cabazitaxel—TUBB1—central nervous system—malignant glioma	0.00377	0.0165	CbGeAlD
Cabazitaxel—TUBB3—cerebellum—malignant glioma	0.00377	0.0165	CbGeAlD
Cabazitaxel—TUBB2A—telencephalon—malignant glioma	0.00376	0.0164	CbGeAlD
Cabazitaxel—TUBA4A—midbrain—malignant glioma	0.0037	0.0162	CbGeAlD
Cabazitaxel—TUBA4A—spinal cord—malignant glioma	0.00361	0.0158	CbGeAlD
Cabazitaxel—TUBB4B—retina—malignant glioma	0.0035	0.0153	CbGeAlD
Cabazitaxel—Hot flush—Temozolomide—malignant glioma	0.00328	0.01	CcSEcCtD
Cabazitaxel—Menopausal symptoms—Temozolomide—malignant glioma	0.00325	0.00994	CcSEcCtD
Cabazitaxel—TUBB4A—medulla oblongata—malignant glioma	0.00325	0.0142	CbGeAlD
Cabazitaxel—TUBB4B—telencephalon—malignant glioma	0.00322	0.0141	CbGeAlD
Cabazitaxel—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.00318	0.00971	CcSEcCtD
Cabazitaxel—TUBB2B—medulla oblongata—malignant glioma	0.00314	0.0137	CbGeAlD
Cabazitaxel—TUBB3—brain—malignant glioma	0.00306	0.0134	CbGeAlD
Cabazitaxel—TUBB1—brain—malignant glioma	0.003	0.0131	CbGeAlD
Cabazitaxel—TUBB—medulla oblongata—malignant glioma	0.00297	0.013	CbGeAlD
Cabazitaxel—TUBB4A—midbrain—malignant glioma	0.00297	0.013	CbGeAlD
Cabazitaxel—TUBB2A—medulla oblongata—malignant glioma	0.00295	0.0129	CbGeAlD
Cabazitaxel—TUBA4A—central nervous system—malignant glioma	0.00293	0.0128	CbGeAlD
Cabazitaxel—TUBB6—medulla oblongata—malignant glioma	0.00291	0.0127	CbGeAlD
Cabazitaxel—TUBB4A—spinal cord—malignant glioma	0.0029	0.0127	CbGeAlD
Cabazitaxel—Hypokalaemia—Carmustine—malignant glioma	0.00289	0.00883	CcSEcCtD
Cabazitaxel—TUBB2B—midbrain—malignant glioma	0.00287	0.0125	CbGeAlD
Cabazitaxel—TUBA4A—cerebellum—malignant glioma	0.00286	0.0125	CbGeAlD
Cabazitaxel—Dehydration—Temozolomide—malignant glioma	0.00285	0.00872	CcSEcCtD
Cabazitaxel—Dry skin—Temozolomide—malignant glioma	0.00281	0.0086	CcSEcCtD
Cabazitaxel—TUBB2B—spinal cord—malignant glioma	0.0028	0.0122	CbGeAlD
Cabazitaxel—Hypokalaemia—Temozolomide—malignant glioma	0.00279	0.00854	CcSEcCtD
Cabazitaxel—Breast disorder—Temozolomide—malignant glioma	0.00277	0.00848	CcSEcCtD
Cabazitaxel—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.00276	0.00845	CcSEcCtD
Cabazitaxel—TUBB—midbrain—malignant glioma	0.00271	0.0119	CbGeAlD
Cabazitaxel—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.00271	0.00827	CcSEcCtD
Cabazitaxel—TUBB2A—midbrain—malignant glioma	0.0027	0.0118	CbGeAlD
Cabazitaxel—Abdominal distension—Temozolomide—malignant glioma	0.00267	0.00816	CcSEcCtD
Cabazitaxel—TUBB6—midbrain—malignant glioma	0.00266	0.0116	CbGeAlD
Cabazitaxel—TUBB—spinal cord—malignant glioma	0.00265	0.0116	CbGeAlD
Cabazitaxel—TUBB2A—spinal cord—malignant glioma	0.00263	0.0115	CbGeAlD
Cabazitaxel—TUBB6—spinal cord—malignant glioma	0.0026	0.0114	CbGeAlD
Cabazitaxel—Neutropenia—Carmustine—malignant glioma	0.00257	0.00784	CcSEcCtD
Cabazitaxel—TUBB4B—medulla oblongata—malignant glioma	0.00253	0.0111	CbGeAlD
Cabazitaxel—Neutropenia—Temozolomide—malignant glioma	0.00248	0.00758	CcSEcCtD
Cabazitaxel—Dysuria—Temozolomide—malignant glioma	0.00248	0.00758	CcSEcCtD
Cabazitaxel—Hyperglycaemia—Carmustine—malignant glioma	0.00248	0.00757	CcSEcCtD
Cabazitaxel—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00247	0.00753	CcSEcCtD
Cabazitaxel—Pneumonia—Carmustine—malignant glioma	0.00246	0.00752	CcSEcCtD
Cabazitaxel—Pollakiuria—Temozolomide—malignant glioma	0.00245	0.00749	CcSEcCtD
Cabazitaxel—Renal failure—Carmustine—malignant glioma	0.00241	0.00735	CcSEcCtD
Cabazitaxel—Weight decreased—Temozolomide—malignant glioma	0.0024	0.00733	CcSEcCtD
Cabazitaxel—Neuropathy peripheral—Carmustine—malignant glioma	0.0024	0.00733	CcSEcCtD
Cabazitaxel—Hyperglycaemia—Temozolomide—malignant glioma	0.00239	0.00731	CcSEcCtD
Cabazitaxel—Urinary tract infection—Carmustine—malignant glioma	0.00238	0.00727	CcSEcCtD
Cabazitaxel—Pneumonia—Temozolomide—malignant glioma	0.00238	0.00727	CcSEcCtD
Cabazitaxel—Infestation NOS—Temozolomide—malignant glioma	0.00237	0.00723	CcSEcCtD
Cabazitaxel—Infestation—Temozolomide—malignant glioma	0.00237	0.00723	CcSEcCtD
Cabazitaxel—TUBB4A—central nervous system—malignant glioma	0.00235	0.0103	CbGeAlD
Cabazitaxel—TUBA4A—brain—malignant glioma	0.00233	0.0102	CbGeAlD
Cabazitaxel—Neuropathy peripheral—Temozolomide—malignant glioma	0.00232	0.00708	CcSEcCtD
Cabazitaxel—TUBB4B—midbrain—malignant glioma	0.00231	0.0101	CbGeAlD
Cabazitaxel—Urinary tract infection—Temozolomide—malignant glioma	0.0023	0.00703	CcSEcCtD
Cabazitaxel—TUBB4A—cerebellum—malignant glioma	0.0023	0.01	CbGeAlD
Cabazitaxel—TUBB2B—central nervous system—malignant glioma	0.00227	0.00993	CbGeAlD
Cabazitaxel—TUBB4B—spinal cord—malignant glioma	0.00226	0.00987	CbGeAlD
Cabazitaxel—TUBB2B—cerebellum—malignant glioma	0.00222	0.0097	CbGeAlD
Cabazitaxel—Hypoaesthesia—Carmustine—malignant glioma	0.00219	0.00668	CcSEcCtD
Cabazitaxel—Oedema peripheral—Carmustine—malignant glioma	0.00216	0.00661	CcSEcCtD
Cabazitaxel—Connective tissue disorder—Carmustine—malignant glioma	0.00216	0.0066	CcSEcCtD
Cabazitaxel—TUBB2A—central nervous system—malignant glioma	0.00214	0.00934	CbGeAlD
Cabazitaxel—Hypoaesthesia—Temozolomide—malignant glioma	0.00211	0.00646	CcSEcCtD
Cabazitaxel—TUBB6—central nervous system—malignant glioma	0.00211	0.00922	CbGeAlD
Cabazitaxel—TUBB—cerebellum—malignant glioma	0.0021	0.00918	CbGeAlD
Cabazitaxel—Urinary tract disorder—Temozolomide—malignant glioma	0.0021	0.00641	CcSEcCtD
Cabazitaxel—Oedema peripheral—Temozolomide—malignant glioma	0.00209	0.00639	CcSEcCtD
Cabazitaxel—TUBB2A—cerebellum—malignant glioma	0.00209	0.00913	CbGeAlD
Cabazitaxel—Connective tissue disorder—Temozolomide—malignant glioma	0.00209	0.00638	CcSEcCtD
Cabazitaxel—Urethral disorder—Temozolomide—malignant glioma	0.00208	0.00636	CcSEcCtD
Cabazitaxel—TUBB6—cerebellum—malignant glioma	0.00206	0.00901	CbGeAlD
Cabazitaxel—Eye disorder—Carmustine—malignant glioma	0.00205	0.00627	CcSEcCtD
Cabazitaxel—Flushing—Carmustine—malignant glioma	0.00204	0.00623	CcSEcCtD
Cabazitaxel—Eye disorder—Temozolomide—malignant glioma	0.00198	0.00606	CcSEcCtD
Cabazitaxel—Tinnitus—Temozolomide—malignant glioma	0.00198	0.00605	CcSEcCtD
Cabazitaxel—Cardiac disorder—Temozolomide—malignant glioma	0.00197	0.00602	CcSEcCtD
Cabazitaxel—Flushing—Temozolomide—malignant glioma	0.00197	0.00602	CcSEcCtD
Cabazitaxel—Arrhythmia—Carmustine—malignant glioma	0.00196	0.006	CcSEcCtD
Cabazitaxel—Alopecia—Carmustine—malignant glioma	0.00194	0.00593	CcSEcCtD
Cabazitaxel—ABCB1—blood vessel—malignant glioma	0.00193	0.00845	CbGeAlD
Cabazitaxel—Angiopathy—Temozolomide—malignant glioma	0.00193	0.00589	CcSEcCtD
Cabazitaxel—Mental disorder—Carmustine—malignant glioma	0.00193	0.00588	CcSEcCtD
Cabazitaxel—Immune system disorder—Temozolomide—malignant glioma	0.00192	0.00586	CcSEcCtD
Cabazitaxel—Mediastinal disorder—Temozolomide—malignant glioma	0.00191	0.00585	CcSEcCtD
Cabazitaxel—Malnutrition—Carmustine—malignant glioma	0.00191	0.00584	CcSEcCtD
Cabazitaxel—Erythema—Carmustine—malignant glioma	0.00191	0.00584	CcSEcCtD
Cabazitaxel—Chills—Temozolomide—malignant glioma	0.00191	0.00582	CcSEcCtD
Cabazitaxel—ABCG2—telencephalon—malignant glioma	0.0019	0.00831	CbGeAlD
Cabazitaxel—Alopecia—Temozolomide—malignant glioma	0.00188	0.00573	CcSEcCtD
Cabazitaxel—TUBB4A—brain—malignant glioma	0.00186	0.00815	CbGeAlD
Cabazitaxel—Mental disorder—Temozolomide—malignant glioma	0.00186	0.00568	CcSEcCtD
Cabazitaxel—Back pain—Carmustine—malignant glioma	0.00185	0.00565	CcSEcCtD
Cabazitaxel—Erythema—Temozolomide—malignant glioma	0.00185	0.00565	CcSEcCtD
Cabazitaxel—Malnutrition—Temozolomide—malignant glioma	0.00185	0.00565	CcSEcCtD
Cabazitaxel—TUBB4B—central nervous system—malignant glioma	0.00183	0.00801	CbGeAlD
Cabazitaxel—Dysgeusia—Temozolomide—malignant glioma	0.00181	0.00553	CcSEcCtD
Cabazitaxel—TUBB2B—brain—malignant glioma	0.0018	0.00788	CbGeAlD
Cabazitaxel—TUBB4B—cerebellum—malignant glioma	0.00179	0.00783	CbGeAlD
Cabazitaxel—Back pain—Temozolomide—malignant glioma	0.00179	0.00546	CcSEcCtD
Cabazitaxel—Anaemia—Carmustine—malignant glioma	0.00177	0.0054	CcSEcCtD
Cabazitaxel—Ill-defined disorder—Temozolomide—malignant glioma	0.00172	0.00524	CcSEcCtD
Cabazitaxel—Leukopenia—Carmustine—malignant glioma	0.00171	0.00523	CcSEcCtD
Cabazitaxel—Anaemia—Temozolomide—malignant glioma	0.00171	0.00522	CcSEcCtD
Cabazitaxel—TUBB—brain—malignant glioma	0.00171	0.00746	CbGeAlD
Cabazitaxel—TUBB2A—brain—malignant glioma	0.0017	0.00742	CbGeAlD
Cabazitaxel—TUBB6—brain—malignant glioma	0.00167	0.00732	CbGeAlD
Cabazitaxel—Malaise—Temozolomide—malignant glioma	0.00167	0.00509	CcSEcCtD
Cabazitaxel—Vertigo—Temozolomide—malignant glioma	0.00166	0.00507	CcSEcCtD
Cabazitaxel—Leukopenia—Temozolomide—malignant glioma	0.00165	0.00506	CcSEcCtD
Cabazitaxel—Hypertension—Carmustine—malignant glioma	0.00165	0.00505	CcSEcCtD
Cabazitaxel—Chest pain—Carmustine—malignant glioma	0.00163	0.00498	CcSEcCtD
Cabazitaxel—Myalgia—Carmustine—malignant glioma	0.00163	0.00498	CcSEcCtD
Cabazitaxel—Anxiety—Carmustine—malignant glioma	0.00162	0.00496	CcSEcCtD
Cabazitaxel—Cough—Temozolomide—malignant glioma	0.00161	0.00493	CcSEcCtD
Cabazitaxel—Hypertension—Temozolomide—malignant glioma	0.0016	0.00488	CcSEcCtD
Cabazitaxel—Confusional state—Carmustine—malignant glioma	0.00157	0.00481	CcSEcCtD
Cabazitaxel—Myalgia—Temozolomide—malignant glioma	0.00157	0.00481	CcSEcCtD
Cabazitaxel—Arthralgia—Temozolomide—malignant glioma	0.00157	0.00481	CcSEcCtD
Cabazitaxel—Anxiety—Temozolomide—malignant glioma	0.00157	0.00479	CcSEcCtD
Cabazitaxel—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00156	0.00478	CcSEcCtD
Cabazitaxel—Oedema—Carmustine—malignant glioma	0.00156	0.00477	CcSEcCtD
Cabazitaxel—Discomfort—Temozolomide—malignant glioma	0.00156	0.00475	CcSEcCtD
Cabazitaxel—Infection—Carmustine—malignant glioma	0.00155	0.00474	CcSEcCtD
Cabazitaxel—Dry mouth—Temozolomide—malignant glioma	0.00154	0.0047	CcSEcCtD
Cabazitaxel—Thrombocytopenia—Carmustine—malignant glioma	0.00153	0.00467	CcSEcCtD
Cabazitaxel—Tachycardia—Carmustine—malignant glioma	0.00152	0.00466	CcSEcCtD
Cabazitaxel—Confusional state—Temozolomide—malignant glioma	0.00152	0.00465	CcSEcCtD
Cabazitaxel—Oedema—Temozolomide—malignant glioma	0.00151	0.00461	CcSEcCtD
Cabazitaxel—Infection—Temozolomide—malignant glioma	0.0015	0.00458	CcSEcCtD
Cabazitaxel—ABCG2—medulla oblongata—malignant glioma	0.00149	0.00653	CbGeAlD
Cabazitaxel—Anorexia—Carmustine—malignant glioma	0.00149	0.00455	CcSEcCtD
Cabazitaxel—Nervous system disorder—Temozolomide—malignant glioma	0.00148	0.00452	CcSEcCtD
Cabazitaxel—Thrombocytopenia—Temozolomide—malignant glioma	0.00148	0.00451	CcSEcCtD
Cabazitaxel—Skin disorder—Temozolomide—malignant glioma	0.00147	0.00448	CcSEcCtD
Cabazitaxel—Hypotension—Carmustine—malignant glioma	0.00146	0.00446	CcSEcCtD
Cabazitaxel—TUBB4B—brain—malignant glioma	0.00145	0.00636	CbGeAlD
Cabazitaxel—Anorexia—Temozolomide—malignant glioma	0.00144	0.00439	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00142	0.00435	CcSEcCtD
Cabazitaxel—Paraesthesia—Carmustine—malignant glioma	0.0014	0.00428	CcSEcCtD
Cabazitaxel—Dyspnoea—Carmustine—malignant glioma	0.00139	0.00425	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00137	0.0042	CcSEcCtD
Cabazitaxel—ABCG2—midbrain—malignant glioma	0.00137	0.00597	CbGeAlD
Cabazitaxel—Decreased appetite—Carmustine—malignant glioma	0.00136	0.00415	CcSEcCtD
Cabazitaxel—Paraesthesia—Temozolomide—malignant glioma	0.00135	0.00414	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Carmustine—malignant glioma	0.00135	0.00412	CcSEcCtD
Cabazitaxel—Dyspnoea—Temozolomide—malignant glioma	0.00135	0.00411	CcSEcCtD
Cabazitaxel—Constipation—Carmustine—malignant glioma	0.00134	0.00408	CcSEcCtD
Cabazitaxel—Pain—Carmustine—malignant glioma	0.00134	0.00408	CcSEcCtD
Cabazitaxel—ABCG2—spinal cord—malignant glioma	0.00133	0.00582	CbGeAlD
Cabazitaxel—Dyspepsia—Temozolomide—malignant glioma	0.00133	0.00406	CcSEcCtD
Cabazitaxel—Decreased appetite—Temozolomide—malignant glioma	0.00131	0.00401	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Temozolomide—malignant glioma	0.0013	0.00398	CcSEcCtD
Cabazitaxel—Fatigue—Temozolomide—malignant glioma	0.0013	0.00397	CcSEcCtD
Cabazitaxel—Pain—Temozolomide—malignant glioma	0.00129	0.00394	CcSEcCtD
Cabazitaxel—Constipation—Temozolomide—malignant glioma	0.00129	0.00394	CcSEcCtD
Cabazitaxel—Feeling abnormal—Carmustine—malignant glioma	0.00129	0.00393	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Carmustine—malignant glioma	0.00128	0.0039	CcSEcCtD
Cabazitaxel—Feeling abnormal—Temozolomide—malignant glioma	0.00124	0.0038	CcSEcCtD
Cabazitaxel—Abdominal pain—Carmustine—malignant glioma	0.00123	0.00377	CcSEcCtD
Cabazitaxel—Body temperature increased—Carmustine—malignant glioma	0.00123	0.00377	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Temozolomide—malignant glioma	0.00123	0.00377	CcSEcCtD
Cabazitaxel—Body temperature increased—Temozolomide—malignant glioma	0.00119	0.00364	CcSEcCtD
Cabazitaxel—Abdominal pain—Temozolomide—malignant glioma	0.00119	0.00364	CcSEcCtD
Cabazitaxel—ABCB1—embryo—malignant glioma	0.00115	0.00504	CbGeAlD
Cabazitaxel—Hypersensitivity—Carmustine—malignant glioma	0.00115	0.00351	CcSEcCtD
Cabazitaxel—Asthenia—Carmustine—malignant glioma	0.00112	0.00342	CcSEcCtD
Cabazitaxel—Hypersensitivity—Temozolomide—malignant glioma	0.00111	0.0034	CcSEcCtD
Cabazitaxel—Asthenia—Temozolomide—malignant glioma	0.00108	0.00331	CcSEcCtD
Cabazitaxel—Diarrhoea—Carmustine—malignant glioma	0.00107	0.00326	CcSEcCtD
Cabazitaxel—ABCG2—cerebellum—malignant glioma	0.00106	0.00462	CbGeAlD
Cabazitaxel—Dizziness—Carmustine—malignant glioma	0.00103	0.00315	CcSEcCtD
Cabazitaxel—Diarrhoea—Temozolomide—malignant glioma	0.00103	0.00315	CcSEcCtD
Cabazitaxel—ABCB1—retina—malignant glioma	0.00102	0.00446	CbGeAlD
Cabazitaxel—Dizziness—Temozolomide—malignant glioma	0.000998	0.00305	CcSEcCtD
Cabazitaxel—Vomiting—Carmustine—malignant glioma	0.000993	0.00303	CcSEcCtD
Cabazitaxel—Headache—Carmustine—malignant glioma	0.000978	0.00299	CcSEcCtD
Cabazitaxel—Vomiting—Temozolomide—malignant glioma	0.000959	0.00293	CcSEcCtD
Cabazitaxel—Headache—Temozolomide—malignant glioma	0.000945	0.00289	CcSEcCtD
Cabazitaxel—ABCB1—telencephalon—malignant glioma	0.000937	0.0041	CbGeAlD
Cabazitaxel—Nausea—Carmustine—malignant glioma	0.000927	0.00283	CcSEcCtD
Cabazitaxel—Nausea—Temozolomide—malignant glioma	0.000896	0.00274	CcSEcCtD
Cabazitaxel—CYP2C8—brain—malignant glioma	0.000882	0.00386	CbGeAlD
Cabazitaxel—ABCG2—brain—malignant glioma	0.000858	0.00375	CbGeAlD
Cabazitaxel—CYP3A4—central nervous system—malignant glioma	0.000753	0.00329	CbGeAlD
Cabazitaxel—ABCB1—medulla oblongata—malignant glioma	0.000736	0.00322	CbGeAlD
Cabazitaxel—ABCB1—midbrain—malignant glioma	0.000673	0.00294	CbGeAlD
Cabazitaxel—ABCB1—spinal cord—malignant glioma	0.000657	0.00287	CbGeAlD
Cabazitaxel—ABCB1—central nervous system—malignant glioma	0.000533	0.00233	CbGeAlD
Cabazitaxel—ABCB1—cerebellum—malignant glioma	0.000521	0.00228	CbGeAlD
Cabazitaxel—ABCB1—brain—malignant glioma	0.000423	0.00185	CbGeAlD
Cabazitaxel—TUBB1—Metabolism of proteins—MMP2—malignant glioma	9.73e-05	0.00023	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	9.72e-05	0.000229	CbGpPWpGaD
Cabazitaxel—TUBB2A—Transmembrane transport of small molecules—RAF1—malignant glioma	9.7e-05	0.000229	CbGpPWpGaD
Cabazitaxel—ABCG2—Transmembrane transport of small molecules—SLC6A3—malignant glioma	9.66e-05	0.000228	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—CDKN2A—malignant glioma	9.61e-05	0.000227	CbGpPWpGaD
Cabazitaxel—TUBB1—Transmembrane transport of small molecules—RAF1—malignant glioma	9.49e-05	0.000224	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	9.43e-05	0.000223	CbGpPWpGaD
Cabazitaxel—TUBB4B—Metabolism of proteins—F2—malignant glioma	9.42e-05	0.000222	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—MDM2—malignant glioma	9.32e-05	0.00022	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—COX8A—malignant glioma	9.32e-05	0.00022	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle—MYC—malignant glioma	9.24e-05	0.000218	CbGpPWpGaD
Cabazitaxel—ABCB1—Allograft Rejection—VEGFA—malignant glioma	9.21e-05	0.000217	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	9.1e-05	0.000215	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—IDH2—malignant glioma	9.05e-05	0.000214	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—KRAS—malignant glioma	9.05e-05	0.000214	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—GSTT1—malignant glioma	8.88e-05	0.00021	CbGpPWpGaD
Cabazitaxel—TUBB6—Metabolism of proteins—CXCL8—malignant glioma	8.84e-05	0.000209	CbGpPWpGaD
Cabazitaxel—TUBB2B—Metabolism of proteins—CXCL8—malignant glioma	8.84e-05	0.000209	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle, Mitotic—MYC—malignant glioma	8.79e-05	0.000207	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—CDKN2A—malignant glioma	8.79e-05	0.000207	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	8.75e-05	0.000207	CbGpPWpGaD
Cabazitaxel—TUBB4A—Metabolism of proteins—MMP2—malignant glioma	8.74e-05	0.000206	CbGpPWpGaD
Cabazitaxel—TUBB3—Metabolism of proteins—CXCL8—malignant glioma	8.54e-05	0.000202	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	8.53e-05	0.000201	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—MDM2—malignant glioma	8.52e-05	0.000201	CbGpPWpGaD
Cabazitaxel—TUBB4A—Transmembrane transport of small molecules—RAF1—malignant glioma	8.52e-05	0.000201	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—CYP2B6—malignant glioma	8.51e-05	0.000201	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—IDH2—malignant glioma	8.38e-05	0.000198	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—PTGS1—malignant glioma	8.32e-05	0.000196	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—PIK3CA—malignant glioma	8.31e-05	0.000196	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	8.29e-05	0.000196	CbGpPWpGaD
Cabazitaxel—TUBB2A—Metabolism of proteins—CXCL8—malignant glioma	8.27e-05	0.000195	CbGpPWpGaD
Cabazitaxel—TUBB1—Metabolism of proteins—CXCL8—malignant glioma	8.09e-05	0.000191	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—COX8A—malignant glioma	8.07e-05	0.00019	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—TP53—malignant glioma	8.04e-05	0.00019	CbGpPWpGaD
Cabazitaxel—TUBB4B—Metabolism of proteins—MMP2—malignant glioma	7.99e-05	0.000189	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—ASMT—malignant glioma	7.92e-05	0.000187	CbGpPWpGaD
Cabazitaxel—ABCB1—Allograft Rejection—TNF—malignant glioma	7.89e-05	0.000186	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—CYP2B6—malignant glioma	7.88e-05	0.000186	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle—MYC—malignant glioma	7.86e-05	0.000185	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	7.84e-05	0.000185	CbGpPWpGaD
Cabazitaxel—TUBB4B—Transmembrane transport of small molecules—RAF1—malignant glioma	7.79e-05	0.000184	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—IDH1—malignant glioma	7.78e-05	0.000184	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—BCHE—malignant glioma	7.74e-05	0.000183	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—SLC5A5—malignant glioma	7.64e-05	0.00018	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	7.6e-05	0.000179	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle—TP53—malignant glioma	7.59e-05	0.000179	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—RTEL1—malignant glioma	7.54e-05	0.000178	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—SPHK1—malignant glioma	7.53e-05	0.000178	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	7.51e-05	0.000177	CbGpPWpGaD
Cabazitaxel—CYP3A4—Biological oxidations—GSTP1—malignant glioma	7.46e-05	0.000176	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—BCAN—malignant glioma	7.45e-05	0.000176	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—CYP2C18—malignant glioma	7.38e-05	0.000174	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	7.36e-05	0.000174	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle, Mitotic—MYC—malignant glioma	7.28e-05	0.000172	CbGpPWpGaD
Cabazitaxel—TUBB4A—Metabolism of proteins—CXCL8—malignant glioma	7.26e-05	0.000171	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	7.23e-05	0.000171	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	7.21e-05	0.00017	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—IDH1—malignant glioma	7.21e-05	0.00017	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	7.16e-05	0.000169	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Transmembrane transport of small molecules—RAF1—malignant glioma	7.04e-05	0.000166	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—COX8A—malignant glioma	7.03e-05	0.000166	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—SPHK1—malignant glioma	6.97e-05	0.000165	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	6.96e-05	0.000164	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—ASMT—malignant glioma	6.86e-05	0.000162	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—CYP2C18—malignant glioma	6.83e-05	0.000161	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—AKT1—malignant glioma	6.79e-05	0.00016	CbGpPWpGaD
Cabazitaxel—ABCB1—HIF-1-alpha transcription factor network—AKT1—malignant glioma	6.78e-05	0.00016	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	6.71e-05	0.000158	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle, Mitotic—MYC—malignant glioma	6.66e-05	0.000157	CbGpPWpGaD
Cabazitaxel—TUBB4B—Metabolism of proteins—CXCL8—malignant glioma	6.64e-05	0.000157	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—MYC—malignant glioma	6.51e-05	0.000154	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle—TP53—malignant glioma	6.45e-05	0.000152	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—BCAN—malignant glioma	6.45e-05	0.000152	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	6.39e-05	0.000151	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	6.34e-05	0.00015	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	6.24e-05	0.000147	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—GSTP1—malignant glioma	6.16e-05	0.000145	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	6.12e-05	0.000144	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	6.07e-05	0.000143	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—IDH2—malignant glioma	6e-05	0.000142	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—CAT—malignant glioma	5.99e-05	0.000141	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	5.98e-05	0.000141	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—ASMT—malignant glioma	5.98e-05	0.000141	CbGpPWpGaD
Cabazitaxel—ABCB1—Transmembrane transport of small molecules—TFRC—malignant glioma	5.98e-05	0.000141	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—GSTT1—malignant glioma	5.97e-05	0.000141	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	5.96e-05	0.000141	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—MYC—malignant glioma	5.95e-05	0.000141	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	5.9e-05	0.000139	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	5.77e-05	0.000136	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—NCOR1—malignant glioma	5.66e-05	0.000133	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—CYP2B6—malignant glioma	5.64e-05	0.000133	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—BCAN—malignant glioma	5.62e-05	0.000133	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—PTGS1—malignant glioma	5.59e-05	0.000132	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	5.57e-05	0.000131	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—GSTT1—malignant glioma	5.52e-05	0.00013	CbGpPWpGaD
Cabazitaxel—ABCB1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	5.49e-05	0.00013	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	5.35e-05	0.000126	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—TP53—malignant glioma	5.35e-05	0.000126	CbGpPWpGaD
Cabazitaxel—ABCB1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	5.22e-05	0.000123	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—IDH2—malignant glioma	5.2e-05	0.000123	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—BCHE—malignant glioma	5.2e-05	0.000123	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—PTGS1—malignant glioma	5.18e-05	0.000122	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—IDH1—malignant glioma	5.16e-05	0.000122	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—SLC5A5—malignant glioma	5.13e-05	0.000121	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	5.03e-05	0.000119	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—SPHK1—malignant glioma	5e-05	0.000118	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	4.9e-05	0.000116	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—CYP2C18—malignant glioma	4.89e-05	0.000116	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—TP53—malignant glioma	4.89e-05	0.000115	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—CYP2B6—malignant glioma	4.89e-05	0.000115	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	4.86e-05	0.000115	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—BCHE—malignant glioma	4.81e-05	0.000114	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	4.81e-05	0.000114	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—SLC5A5—malignant glioma	4.75e-05	0.000112	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Transmembrane transport of small molecules—RAF1—malignant glioma	4.73e-05	0.000112	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—CAV1—malignant glioma	4.61e-05	0.000109	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	4.54e-05	0.000107	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—IDH2—malignant glioma	4.53e-05	0.000107	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—IDH1—malignant glioma	4.47e-05	0.000106	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	4.41e-05	0.000104	CbGpPWpGaD
Cabazitaxel—ABCG2—Transmembrane transport of small molecules—RAF1—malignant glioma	4.38e-05	0.000103	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—COX8A—malignant glioma	4.33e-05	0.000102	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—SPHK1—malignant glioma	4.33e-05	0.000102	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—CYP2B6—malignant glioma	4.26e-05	0.000101	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—CYP2C18—malignant glioma	4.24e-05	0.0001	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—PIK3CG—malignant glioma	4.2e-05	9.91e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	4.2e-05	9.9e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	4.18e-05	9.86e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—GSTP1—malignant glioma	4.14e-05	9.76e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	4.09e-05	9.65e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—PPARG—malignant glioma	4.05e-05	9.57e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—CAT—malignant glioma	4.02e-05	9.5e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	4e-05	9.43e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—GSTT1—malignant glioma	3.96e-05	9.34e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—IDH1—malignant glioma	3.9e-05	9.19e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	3.89e-05	9.19e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	3.86e-05	9.11e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—GSTP1—malignant glioma	3.83e-05	9.04e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—NCOR1—malignant glioma	3.8e-05	8.97e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—SPHK1—malignant glioma	3.77e-05	8.9e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—CAT—malignant glioma	3.73e-05	8.79e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PTGS1—malignant glioma	3.71e-05	8.75e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—CYP2C18—malignant glioma	3.69e-05	8.72e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—PIK3CD—malignant glioma	3.69e-05	8.71e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—ASMT—malignant glioma	3.68e-05	8.69e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	3.64e-05	8.59e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	3.55e-05	8.37e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—NCOR1—malignant glioma	3.52e-05	8.3e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	3.51e-05	8.29e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—BCAN—malignant glioma	3.46e-05	8.17e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—BCHE—malignant glioma	3.45e-05	8.14e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	3.43e-05	8.1e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—GSTT1—malignant glioma	3.43e-05	8.09e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—SLC5A5—malignant glioma	3.41e-05	8.04e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—PIK3CB—malignant glioma	3.22e-05	7.6e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PTGS1—malignant glioma	3.21e-05	7.58e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	3.2e-05	7.55e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—PTGS2—malignant glioma	3.19e-05	7.53e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—CAV1—malignant glioma	3.1e-05	7.31e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—GSTT1—malignant glioma	2.99e-05	7.05e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—BCHE—malignant glioma	2.99e-05	7.05e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.96e-05	6.99e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—SLC5A5—malignant glioma	2.95e-05	6.96e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	2.9e-05	6.84e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—CAV1—malignant glioma	2.87e-05	6.77e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—PIK3CG—malignant glioma	2.82e-05	6.66e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PTGS1—malignant glioma	2.8e-05	6.61e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—IDH2—malignant glioma	2.79e-05	6.59e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.79e-05	6.58e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—PTEN—malignant glioma	2.78e-05	6.56e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.76e-05	6.52e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—GSTP1—malignant glioma	2.74e-05	6.47e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—PPARG—malignant glioma	2.72e-05	6.43e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—CAT—malignant glioma	2.67e-05	6.3e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—CYP2B6—malignant glioma	2.62e-05	6.19e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—PIK3CG—malignant glioma	2.61e-05	6.17e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—BCHE—malignant glioma	2.6e-05	6.14e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—SLC5A5—malignant glioma	2.57e-05	6.07e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—PPARG—malignant glioma	2.52e-05	5.95e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—NCOR1—malignant glioma	2.52e-05	5.95e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—PIK3CD—malignant glioma	2.48e-05	5.85e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.41e-05	5.69e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—IDH1—malignant glioma	2.4e-05	5.66e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—GSTP1—malignant glioma	2.38e-05	5.61e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	2.37e-05	5.59e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—SPHK1—malignant glioma	2.32e-05	5.48e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—CAT—malignant glioma	2.31e-05	5.46e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—PIK3CD—malignant glioma	2.3e-05	5.42e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—CYP2C18—malignant glioma	2.28e-05	5.37e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—NCOR1—malignant glioma	2.18e-05	5.15e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—PIK3CB—malignant glioma	2.16e-05	5.1e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—PTGS2—malignant glioma	2.14e-05	5.06e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—GSTP1—malignant glioma	2.07e-05	4.89e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—CAV1—malignant glioma	2.06e-05	4.85e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—CAT—malignant glioma	2.01e-05	4.75e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—PIK3CB—malignant glioma	2e-05	4.73e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—PTGS2—malignant glioma	1.98e-05	4.68e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—PIK3CA—malignant glioma	1.96e-05	4.63e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—NCOR1—malignant glioma	1.9e-05	4.49e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PIK3CG—malignant glioma	1.87e-05	4.42e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—PTEN—malignant glioma	1.87e-05	4.41e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—GSTT1—malignant glioma	1.84e-05	4.34e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PPARG—malignant glioma	1.81e-05	4.26e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—CAV1—malignant glioma	1.78e-05	4.2e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—PTEN—malignant glioma	1.73e-05	4.08e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PTGS1—malignant glioma	1.72e-05	4.07e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.7e-05	4.01e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PIK3CD—malignant glioma	1.65e-05	3.88e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PIK3CG—malignant glioma	1.62e-05	3.83e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—BCHE—malignant glioma	1.6e-05	3.78e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—AKT1—malignant glioma	1.6e-05	3.78e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—SLC5A5—malignant glioma	1.58e-05	3.74e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PPARG—malignant glioma	1.56e-05	3.69e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—CAV1—malignant glioma	1.55e-05	3.66e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PIK3CB—malignant glioma	1.43e-05	3.39e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PIK3CD—malignant glioma	1.43e-05	3.36e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PTGS2—malignant glioma	1.42e-05	3.35e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PIK3CG—malignant glioma	1.41e-05	3.33e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PPARG—malignant glioma	1.36e-05	3.22e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—PIK3CA—malignant glioma	1.32e-05	3.11e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—GSTP1—malignant glioma	1.28e-05	3.01e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PIK3CB—malignant glioma	1.24e-05	2.93e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PIK3CD—malignant glioma	1.24e-05	2.93e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—CAT—malignant glioma	1.24e-05	2.93e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PTEN—malignant glioma	1.24e-05	2.93e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PTGS2—malignant glioma	1.23e-05	2.91e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—PIK3CA—malignant glioma	1.22e-05	2.88e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—NCOR1—malignant glioma	1.17e-05	2.77e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PIK3CB—malignant glioma	1.08e-05	2.55e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—AKT1—malignant glioma	1.08e-05	2.54e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PTEN—malignant glioma	1.07e-05	2.53e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PTGS2—malignant glioma	1.07e-05	2.53e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—AKT1—malignant glioma	9.97e-06	2.35e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—CAV1—malignant glioma	9.56e-06	2.26e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PTEN—malignant glioma	9.35e-06	2.21e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PIK3CA—malignant glioma	8.74e-06	2.06e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PIK3CG—malignant glioma	8.7e-06	2.05e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PPARG—malignant glioma	8.4e-06	1.98e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PIK3CD—malignant glioma	7.65e-06	1.81e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PIK3CA—malignant glioma	7.57e-06	1.79e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—AKT1—malignant glioma	7.14e-06	1.69e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PIK3CB—malignant glioma	6.67e-06	1.57e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PTGS2—malignant glioma	6.61e-06	1.56e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PIK3CA—malignant glioma	6.6e-06	1.56e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—AKT1—malignant glioma	6.19e-06	1.46e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PTEN—malignant glioma	5.76e-06	1.36e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—AKT1—malignant glioma	5.39e-06	1.27e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PIK3CA—malignant glioma	4.07e-06	9.59e-06	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—AKT1—malignant glioma	3.32e-06	7.84e-06	CbGpPWpGaD
